General MedicationsORALGeneric

MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE

Standard Dose

1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT

Max Dose

Refer to approved labeling

Primary Use

Marketing status: None (Tentative Approval)

Summary

Approval overview MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE is listed in Drugs@FDA under application 203102 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE Form and strength SOLUTION;ORAL - 1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT Sponsor PADDOCK LLC Submission history Latest submission status date: 2016-08-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE is listed in Drugs@FDA under application 203102 (ANDA). Marketing status: None (Tentative Approval) Active ingredient MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE Form and strength SOLUTION;ORAL - 1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT Sponsor PADDOCK LLC Submission history Latest submission status date: 2016-08-18 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)

Interaction Notes

No interaction notes stored yet.